Home Compliance Biopharma Settlement Questions Assumptions about Anti-Kickback Statute ComplianceExpert Opinion Biopharma Settlement Questions Assumptions about Anti-Kickback Statute January 29, 2024 12 Share FacebookLinkedinTwitter Natali _ Mis | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Expert Opinion The Next Frontier: Key Takeaways from the New U.S. Government Commercial Space Strategies Compliance Not an April Fools Joke – FAR Part 40 Final Rule Has Been Published Compliance A High-Level Overview of the New Cyber Incident Reporting Regulatory Scheme